Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Name | Ropinirole 4mg modified-release tablets |
| BNF code | 0409010H0AAALAL |
| Virtual Therapeutic Moiety | Ropinirole |
| Basis of preferred name | rINN - Recommended International Non-proprietary |
| Prescribing status | Valid as a prescribable product |
| Sugar free | ✗ |
| Gluten free | ✗ |
| Preservative free | ✗ |
| CFC free | ✗ |
| Dose form | Discrete |
| Unit dose form size | 1.000 |
| Unit dose form units | tablet |
| Unit dose unit of measure | tablet |
| Virtual Product Ingredient | |
|---|---|
| Ingredient | Ropinirole hydrochloride |
| Basis of pharmaceutical strength | Based on Base Substance |
| Basis of strength substance identifier | 372499000 |
| Strength value numerator | 4.000 |
| Strength value numerator unit | mg |
| Ontology Drug Form & Route | |
| Form & Route | tabletmodified-release.oral |
| Dose Form | |
| Formulation | Modified-release tablet |
| Drug Route | |
| Route | Oral |
| Controlled Drug Prescribing Information | |
| Controlled Drug category | No Controlled Drug Status |
| Actual Medicinal Products | |
| Ipinnia XL 4mg tablets (Ethypharm UK Ltd) | |
| Ralnea XL 4mg tablets (Krka UK Ltd) | |
| Raponer XL 4mg tablets (Accord-UK Ltd) | |
| Repinex XL 4mg tablets (Aspire Pharma Ltd) | |
| ReQuip XL 4mg tablets (GlaxoSmithKline UK Ltd) | |
| ReQuip XL 4mg tablets (Necessity Supplies Ltd) | |
| ReQuip XL 4mg tablets (Sigma Pharmaceuticals Plc) | |
| Ropinirole 4mg modified-release tablets (Krka UK Ltd) | |
| Ropiqual XL 4mg tablets (Milpharm Ltd) | |
| Virtual Medicinal Product Packs | |
| Ropinirole 4mg modified-release tablets 28 tablet | |
dm+d data retrieved from TRUD: release NHSBSA_5.1.0_20240513000001, imported on 13th May 2024 at 05:02:36.